THE MCLEAN HOSPITAL CORPORATION

The McLean Hospital Corporation specializes in advanced biomedical research and forensic laboratory services, with deep expertise in neuroscience, substance abuse treatment development, and neurobiobanking. The organization conducts preclinical research using nonhuman primate models to evaluate novel pharmacotherapies for addiction, alongside the end-to-end management of brain and tissue repositories for the National Institutes of Health, including acquisition, cryopreservation, curation, and distribution of central nervous system specimens. Their medical laboratory capabilities include forensic toxicology, particularly in the analysis of controlled substances such as benzodiazepines, supporting regulatory oversight for federal law enforcement. Technical strengths encompass neuropharmacology, biospecimen integrity protocols, longitudinal data curation, and compliance with federal biosafety and chain-of-custody standards. Their work bridges clinical neuroscience with applied public health, distinguishing them through rigorous scientific methodology and operational precision in high-sensitivity biological material handling. The contractor maintains a sustained relationship with the Department of Health and Human Services, primarily supporting NIH initiatives in neurobiobanking and addiction therapeutics research. They also deliver forensic toxicology services to the Department of Justice, enabling regulatory monitoring of controlled substances and emerging drugs. These engagements reflect a pattern of trusted, mission-critical support for federal agencies requiring scientifically robust, compliant, and reproducible research and testing infrastructure. Their primary industry focus lies in biotechnology research and medical laboratories, with particular emphasis on neurobiological specimen management and preclinical drug evaluation. This positions them as a niche provider at the intersection of academic neuroscience and federal regulatory science, serving agencies that demand high-integrity biological data and controlled substance analysis. McLean Hospital Corporation is a non-profit healthcare entity based in Belmont, Massachusetts, operating under the 8H entity structure. While no formal government certifications are listed, their consistent performance on sensitive federal contracts demonstrates institutional credibility in handling regulated biological materials and federally funded research. Their geographic presence is centered in Massachusetts, with operations aligned to national biomedical research networks.